BPIFA2 | BPI fold containing family A, member 2 | Predicted secreted proteins
| | | | | Tissue enriched |
HTN3 | Histatin 3 | Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CA6 | Carbonic anhydrase VI | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
MUC7 | Mucin 7, secreted | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
PRR27 | Proline rich 27 | Predicted secreted proteins
| | | | | Tissue enriched |
PIP | Prolactin-induced protein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CST5 | Cystatin D | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SMR3A | Submaxillary gland androgen regulated protein 3A | Predicted secreted proteins
| | | | | Tissue enriched |
LPO | Lactoperoxidase | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ZG16B | Zymogen granule protein 16B | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CST2 | Cystatin SA | Predicted secreted proteins
| | | | | Tissue enriched |
CST4 | Cystatin S | Predicted secreted proteins
| | | | | Tissue enriched |
AMY1C | Amylase, alpha 1C (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
SLC5A5 | Solute carrier family 5 (sodium/iodide cotransporter), member 5 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
BPIFB2 | BPI fold containing family B, member 2 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AMY1A | Amylase, alpha 1A (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CST1 | Cystatin SN | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CALML5 | Calmodulin-like 5 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
PRR4 | Proline rich 4 (lacrimal) | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
C6orf58 | Chromosome 6 open reading frame 58 | Predicted secreted proteins
| | | | | Group enriched |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SOX10 | SRY (sex determining region Y)-box 10 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
DMBT1 | Deleted in malignant brain tumors 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
BHLHA15 | Basic helix-loop-helix family, member a15 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
AMY1B | Amylase, alpha 1B (salivary) | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
NXPE2 | Neurexophilin and PC-esterase domain family, member 2 | Predicted intracellular proteins
| | | | | Group enriched |
ZNF750 | Zinc finger protein 750 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
FDCSP | Follicular dendritic cell secreted protein | Predicted secreted proteins
| | | | | Group enriched |
LYZ | Lysozyme | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
MUCL1 | Mucin-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
PADI2 | Peptidyl arginine deiminase, type II | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
BARX2 | BARX homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN10 | Claudin 10 | Predicted membrane proteins
| | | | | Tissue enhanced |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HSD11B2 | Hydroxysteroid (11-beta) dehydrogenase 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
LRRTM1 | Leucine rich repeat transmembrane neuronal 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PPP1R1B | Protein phosphatase 1, regulatory (inhibitor) subunit 1B | Predicted intracellular proteins
| | | | | Tissue enhanced |
RASAL1 | RAS protein activator like 1 (GAP1 like) | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
TPD52L1 | Tumor protein D52-like 1 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
WFDC2 | WAP four-disulfide core domain 2 | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |